Michael F Maclean - Net Worth and Insider Trading
Michael F Maclean Net Worth
The estimated net worth of Michael F Maclean is at least $4 Million dollars as of 2024-12-28. Michael F Maclean is the CFO of Avidity Biosciences Inc and owns about 82,942 shares of Avidity Biosciences Inc (RNA) stock worth over $2 Million. Michael F Maclean is also the SVP, Chief Accounting Officer of Biogen Inc and owns about 11,634 shares of Biogen Inc (BIIB) stock worth over $2 Million. Details can be seen in Michael F Maclean's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael F Maclean has not made any transactions after 2024-12-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael F Maclean
Michael F Maclean Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael F Maclean owns 4 companies in total, including Avidity Biosciences Inc (RNA) , Akcea Therapeutics Inc (AKCA) , and Biogen Inc (BIIB) among others .
Click here to see the complete history of Michael F Maclean’s form 4 insider trades.
Insider Ownership Summary of Michael F Maclean
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RNA | Avidity Biosciences Inc | 2024-12-18 | Chief Financial Officer |
| AKCA | Akcea Therapeutics Inc | 2020-01-15 | Chief Financial Officer |
| BIIB | Biogen Inc | 2010-08-02 | SVP & Chief Accounting Officer |
 | | 2021-06-16 | director |
Michael F Maclean Latest Holdings Summary
Michael F Maclean currently owns a total of 2 stocks. Among these stocks, Michael F Maclean owns 82,942 shares of Avidity Biosciences Inc (RNA) as of December 18, 2024, with a value of $2 Million and a weighting of 58.66%. Michael F Maclean also owns 11,634 shares of Biogen Inc (BIIB) as of August 2, 2010, with a value of $2 Million and a weighting of 41.34%.
Latest Holdings of Michael F Maclean
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RNA | Avidity Biosciences Inc | 2024-12-18 | 82,942 | 30.11 | 2,497,384 |
| BIIB | Biogen Inc | 2010-08-02 | 11,634 | 151.31 | 1,760,341 |
Holding Weightings of Michael F Maclean
Michael F Maclean Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael F Maclean has made a total of 8 transactions in Avidity Biosciences Inc (RNA) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Avidity Biosciences Inc is the sale of 11,151 shares on December 18, 2024, which brought Michael F Maclean around $364,192.
According to the SEC Form 4 filings, Michael F Maclean has made a total of 0 transactions in Biogen Inc (BIIB) over the past 5 years. The most-recent trade in Biogen Inc is the sale of 9,542 shares on August 2, 2010, which brought Michael F Maclean around $542,463.
Insider Trading History of Michael F Maclean
- 1
Michael F Maclean Trading Performance
Michael F Maclean Ownership Network
Michael F Maclean Owned Company Details
What does Avidity Biosciences Inc do?
Who are the key executives at Avidity Biosciences Inc?
Michael F Maclean is the Chief Financial Officer of Avidity Biosciences Inc. Other key executives at Avidity Biosciences Inc include director & President and CEO Sarah Boyce , Chief Human Resources Officer Teresa Mccarthy , and Chief Technical Officer W. Michael Flanagan .
Avidity Biosciences Inc (RNA) Insider Trades Summary
Over the past 18 months, Michael F Maclean made 8 insider transaction in Avidity Biosciences Inc (RNA) with a net sale of 361,069. Other recent insider transactions involving Avidity Biosciences Inc (RNA) include a net sale of 192,823 shares made by Arthur A Levin , a net sale of 653,901 shares made by Sarah Boyce , and a net sale of 136,233 shares made by Teresa Mccarthy .
In summary, during the past 3 months, insiders sold 373,041 shares of Avidity Biosciences Inc (RNA) in total and bought 0 shares, with a net sale of 373,041 shares. During the past 18 months, 1,623,897 shares of Avidity Biosciences Inc (RNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,623,897 shares.
Avidity Biosciences Inc (RNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avidity Biosciences Inc Insider Transactions
Michael F Maclean Mailing Address
Above is the net worth, insider trading, and ownership report for Michael F Maclean. You might contact Michael F Maclean via mailing address: 14 Cambridge Center, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
